VolitionRX Limited Common Stock (VNRX)
0.5841
0.00 (0.00%)
VolitionRx Ltd is a biotechnology company focused on developing diagnostic tests for detecting a variety of cancers and other diseases through innovative blood-based technologies
The company's primary approach involves utilizing its proprietary Nu.Q platform, which analyzes Nucleosomes—fragments of DNA that can indicate the presence of cancer. By providing accessible and accurate diagnostic tools, VolitionRx aims to enhance early detection and improve patient outcomes in oncology and beyond, ultimately contributing to more effective and personalized healthcare solutions.
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · September 16, 2024
BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) appoints PharmaVentures for Capture PCR(TM) and Oncology Portfolio Licensing
VolitionRx Limited (NYSE American: VNRX), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures will provide strategic advice and transactional support as Volition works towards securing licensing deals with industry leaders for both Nu.Q(R) Cancer – a range of simple blood-based assays to help detect, guide treatment, and monitor cancer, and Capture-PCR(TM) – a novel detection method for liquid biopsy in cancer and potentially other diseases.
Via Investor Brand Network · July 10, 2024
BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) Highlights Latest Achievements in Mid-Year Review
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansion of the Nu.Q(R) Vet Cancer Test, which is now available for purchase in 15 countries. Additionally, Volition is engaged in active commercial discussions with significant players in the fields of liquid biopsy and in vitro diagnostics (“IVD”), for sepsis, and oncology.
Via Investor Brand Network · June 28, 2024
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / June 14, 2024 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) ("Nexalin") and VolitionRX Limited (NYSE American:VNRX) ("Volition") on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 15, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Via ACCESSWIRE · June 14, 2024
VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of the EF Hutton Annual Global Conference
VolitionRx (NYSE American: VNRX) is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring.
Via Investor Brand Network · May 6, 2024
Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV
LAS VEGAS, NV / ACCESSWIRE / April 24, 2023 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 25-27, 2023, where 77 MicroCap public and private companies will be presenting at the Horseshoe Hotel & Casino in Las Vegas, NV.
Via ACCESSWIRE · April 24, 2023
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · March 10, 2023
Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences
NEW YORK, NY / ACCESSWIRE / February 14, 2023 / Sidoti & Company, LLC announces that its two spring conferences are now open for registration. The March Virtual Small-Cap Conference will take place on Wednesday and Thursday, March 22-23, 2023, and the May Virtual Micro-Cap Conference will be on Wednesday and Thursday, May 10-11, 2023.Sidoti hosts eight virtual investor conferences a year, alternating between small- and micro-cap targeted companies. Companies can host both group presentations and private one-on-one meetings with investors. Over 100 companies and 1,000 investors are expected to attend the March conference.
Via ACCESSWIRE · February 14, 2023
Sidoti's January Micro-Cap Conference
NEW YORK, NY / ACCESSWIRE / January 17, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference taking place Wednesday and Thursday, January 18-19, 2023. The links can also be found at www.sidoticonference.com/events.
Via ACCESSWIRE · January 17, 2023
Xenetic Biosciences, Inc. Announces Signing of Patent Assignment Related to Collaboration With VolitionRx Limited and CLS Therapeutics
Signing of patent assignment from CLS Therapeutics as part of a collaboration agreement with Volition and CLS Therapeutics to develop NETs-targeted adoptive cell therapies for the treatment of cancer
Via ACCESSWIRE · October 11, 2022
Sidoti's August Micro-Cap Virtual Conference
NEW YORK, NY / ACCESSWIRE / August 16, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 17-18, 2022. The links can also be found at www.sidoticonference.com/events.
Via ACCESSWIRE · August 16, 2022
Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer
FRAMINGHAM, MA / ACCESSWIRE / August 2, 2022 / Xenetic Biosciences, Inc. (NASDAQXBIO) ("Xenetic"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard-to-treat cancers, and VolitionRx Limited (NYSE AMERICAN:VNRX) ("Volition"), a multi-national epigenetics company, today announced a research and development collaboration to develop Neutrophil Extracellular Traps ("NETs") targeted, adoptive cell therapies for the treatment of cancer.
Via ACCESSWIRE · August 2, 2022
Sidoti December Micro Cap Virtual Conference
Presentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day December Micro Cap Virtual Conference taking place Wednesday and Thursday, December 8 - 9, 2021. The links can also be found at www.sidoticonference.com/events.Group Presentation Schedule (click on co.
By Sidoti & Company, LLC · Via AccessWire · December 7, 2021
Sidoti Microcap Virtual Conference
A Conference Open to All Classes of Investors 70+ Companies Presenting and Meeting Interested Investors 1x1 Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Sidoti & Company, LLC has updated its preliminary list of presenting companies for its two-day Microcap Virtual Conference, taking place Wednesday and Thursday, December 8 - 9, 2021. Currently over 70 microcap companies are expected to present.
By Sidoti & Company, LLC · Via AccessWire · November 5, 2021
VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of Benzinga’s Healthcare Small Cap Conference
VolitionRx Ltd. (NYSE American: VNRX) is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics. For more information, visit the company’s website at www.volition.com
Via Investor Brand Network · September 24, 2021
Sidoti Microcap Virtual Conference
Presentation Times Released for 50 Presenting Companies Wednesday and Thursday, August 18-19, 2021 NEW YORK, NY / ACCESSWIRE / August 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day summer Microcap Virtual Conference taking place Wednesday and Thursday, August 18 - 19, 2021. The links can also be found at www.sidoticonference.com/events. Group Presentation Schedule Click Here to Login /
By Sidoti & Company, LLC · Via AccessWire · August 18, 2021
Diamond Equity Research Emerging Growth Invitational Spring 2021 Virtual Conference
- One Day Conference May 11, 2021 - 25 Minute Presenting Time Slots From 8:30am to 1:25pm EST - Presentation Times and Links Distributed for All Presenting Companies - Investors Will Be Provided Time After Presentation To Ask Questions to Management Teams - We Welcome All Institutional and Retail Investors NEW YORK, NY / ACCESSWIRE / May 6, 2021 / "The Diamond Equity Research Emerging Growth Invitational offers a
By Diamond Equity Research LLC · Via AccessWire · May 6, 2021
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Summer Virtual Event begins on Tuesday, August 17, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers,
By Stock News Now · Via AccessWire · August 16, 2021
Sidoti Summer Virtual Small-Cap Conference
Presentation Times and Weblinks Released for Approximately 70 Presenting Companies Wednesday and Thursday, June 23-24, 2021 NEW YORK, NY / ACCESSWIRE / June 22, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Virtual Small-Cap Conference taking place Wednesday and Thursday, June 23 - 24, 2021. The links can also be found at www.sidoticonference.com/events. Presentation Schedule
By Sidoti & Company, LLC · Via AccessWire · June 22, 2021
Sidoti Microcap Virtual Conference
May 19 - 20, 2021 Presentation times and weblinks released for over 60 presenting companies NEW YORK, NY / ACCESSWIRE / May 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day spring Microcap Virtual Conference taking place Wednesday and Thursday, May 19 - 20, 2021. The links can also be found at www.sidoticonference.com/events. Group Presentation
By Sidoti & Company, LLC · Via AccessWire · May 18, 2021
Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021
LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The Planet MicroCap Showcase: VIRTUAL begins on Tuesday, April 20, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers,
By Stock News Now · Via AccessWire · April 19, 2021